Warning lights
Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.
-
Two loss years in a row NBB
Negative result in 2023 and 2024.
-
Tight liquidity NBB
Cash and receivables cover 45 % of short-term debt in 2024; threshold 65 %.
-
Busy address KBO
28 other companies have their registered office at the same address; threshold 10.
Financials
Financial year 2024
C-Biotech from Temse, company number BE0794909852, closed financial year 2024 with a result of € -628,639 after tax. For that financial year C-Biotech recorded revenue of € 97,133 and equity of € 194,724. Compared with financial year 2023, the result moved from € -431,266 to € -628,639. The company made a loss. The buffer is growing. High debts against a small own buffer. The most recent annual accounts were filed with the National Bank of Belgium on June 27, 2025.
€ 194,724
▲ € 623,990 vs 2023
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ -628,639
▼ 46 % more loss than in 2023
Profit after tax over the fiscal year.
€ 615,584
▲ € 579,596 vs 2023
Cash and bank balances on the last day of the fiscal year.
Loss, nothing to pay out
Reserves fell to € -1.1 million.
People and assets in 2024
1.8
Average over the fiscal year, from the social balance sheet.
€ 107,250
€ 59,600 per full-time equivalent. Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.
Debts at end 2024
€ 600,000
Loans from banks and other lenders, long and short.
€ 438,616
▲ 68% vs 2023
Supplier invoices still open on the last day of the fiscal year.
€ 11,574
Wages, holiday pay and social contributions still to pay. No outstanding taxes.
| 2023 | 2024 | Change 2023 → 2024 | |
|---|---|---|---|
| Revenue | € 119,611 | € 97,133 | ▼ 19% |
| Gross margin | € -410,262 | € -436,301 | ▼ € 26,038 |
| Profit after taxes | € -431,266 | € -628,639 | ▼ € 197,373 |
| Equity | € -429,266 | € 194,724 | ▲ € 623,990 |
| Total debts | € 788,508 | € 2,476,288 | ▲ 214% |
| Cash | € 35,988 | € 615,584 | ▲ € 579,596 |
| Retained profit | € -431,266 | € -1,059,906 | ▼ € 628,639 |
| Bank debt | € 0 | € 600,000 | |
| Balance sheet total | € 359,242 | € 2,671,012 | ▲ € 2.3 million |
| Employees (FTE) | 0 | 1.8 |
Key figures of C-Biotech, fiscal years 2023 to 2024, from the annual accounts filed with the National Bank of Belgium.The annual account for fiscal year 2025 has not been filed yet; it was expected before 31 July 2026.
What happened to C-Biotech?
What happened at C-Biotech in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2024: loss of € 628,639. Source: NBB ↗
- Bert Weemaes BV became a director. NBB
- Nova LaGa BV stepped down as director. NBB
- New establishment in Assesse. KBO
- New establishment in Temse. KBO
- Storm, Wolf & Partners CommV. became a director. NBB
- Nova LaGa BV became a director. NBB
- Start of the company according to the CBE. KBO
In short
From € 431,266 loss in 2023 to € 628,639 loss in 2024.
Management
The stake of FINO comes from that shareholder’s own annual accounts; small companies do not report their shareholders themselves.
C-BiotechBehind C-Biotech are Bert Weemaes BV and Storm, Wolf & Partners CommV.. The shares are held by FINO (50%).
Directors
According to the 2024 annual accounts
Director · represented by Weemaes BERT
Also active at: IMTECH BELGIE, C-Tech Holding, C-LIVING, IMMO MOTCHES, VITA HORECA TEMSE, CORDEEL GROUP, BERNARD CONSTRUCTION, DEMCOR +41 more
since 2025
Director · represented by Verstraete FREDERIK
since 2022
Director · represented by Gacoin LAURENCE
Also active at: C-FIRE, C-LIVING, SOBELTEC, IMMO MOTCHES, C-Energy, VITA HORECA TEMSE, CORDEEL GROUP, VLAECO +37 more
since 2022 · until 2025
Shareholders
50%
Participations
No participations in other companies reported.
Establishments
Establishment units
Physical locations of this company
Frank Van Dyckelaan 15
9140 Temse
Rue du Bois-Gilot 2
5336 Assesse
Active since 29 November 2023
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 28 companies are registered at this address.
All companies at this address →C-FIRE same network
€ 535,397 gross margin · 2025
C-LIVING same network
€ 3.3 million revenue · 2025
C-Energy same network
€ 1 million gross margin · 2025
CORDEEL GROUP same network
€ 10 million revenue · 2025
C-Ground same network
€ -1.5 million gross margin · 2025
+23 more
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 0794.909.852
- VAT number
- BE 0794.909.852
- Registered office
- Frank Van Dyckelaan 15, 9140 Temse
- Names & denominations
- C-Biotech
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 16 December 2022
- Peppol
- Active · Active since 1 Jan 2001
- Activities · NACE
Sanering en ander afvalbeheer